STOCK TITAN

Twist Bioscience (TWST) insider sale notice: 7,470 shares sold; 206 more offered

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TWST Form 144 summary: This notice reports proposed and recent sales of Twist Bioscience common stock by an individual identified as Patrick Finn. The filer proposes to sell 206 shares via Fidelity Brokerage with an aggregate market value of $6,007.15 and lists the company's outstanding share count as 60,360,925. The 206 shares were acquired on 10/01/2025 through restricted stock vesting and payment is listed as compensation. The filing also discloses four reported sales in the prior three months totaling 7,470 shares for $225,564.62. The signer represents they have no undisclosed material information about the issuer.

Positive

  • None.

Negative

  • Insider sold 7,470 shares in the past three months for $225,564.62
  • Proposed sale of 206 shares (aggregate market value $6,007.15) to be executed on 10/02/2025

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

Who is the seller named in the TWST Form 144?

The filing lists Patrick Finn as the person for whose account the securities were or will be sold.

How many shares does the Form 144 propose to sell for TWST?

The notice proposes the sale of 206 shares of common stock with an aggregate market value of $6,007.15.

What recent insider sales are disclosed in this TWST filing?

Four sales in the prior three months totaling 7,470 shares for $225,564.62 (dates: 07/02/2025, 07/23/2025, 08/04/2025, 08/21/2025).

How were the 206 shares being offered for sale acquired?

They were acquired on 10/01/2025 via restricted stock vesting, with consideration listed as compensation.

What outstanding share count does the filing report for TWST?

The filing lists 60,360,925 shares outstanding.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

2.77B
60.26M
1.86%
115.89%
16.96%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO